Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Discover Oncology|May 3, 2026
A lipid nanoparticle-based peptide-proteolysis-targeting chimera degrades BCL6 for diffuse large B-cell lymphoma treatmentShiwei Liu, Xueying Gao, Xuan Ye, et al.
Cancer Medicine|July 27, 2026
Survival Outcomes and Prognostic Factors in Patients With Primary Central Nervous System Low-Grade B-Cell Lymphoma: A Population-Based Cohort StudyLvwen Chen, Lei Cao, Yuxiao Zhao, et al.
Nano Letters|December 20, 2019
Enhanced Piezoelectric Effect Derived from Grain Boundary in MoS2 MonolayersMingjin Dai, Wei Zheng, Xi Zhang, et al.
Human Gene Therapy|July 20, 2018
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T CellsSophia Stock, Jean-Marc Hoffmann, Maria-Luisa Schubert, et al.
Oncology Reports|June 24, 2021
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignanciesSanmei Wang, Leopold Sellner, Lei Wang, et al.
Biomedicines|February 25, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue SarcomaWenjie Gong, Lei Wang, Maria-Luisa Schubert, et al.
Leukemia & Lymphoma|June 11, 2025
Progression of disease within 6 months: revised early disease progression threshold for ENKTLMiao Zhong, Hailing Liu, Renfu Gui, et al.
International Journal of Cancer|July 20, 2020
Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patientsFuli Fan, Hyeon Joo Yoo, Sophia Stock, et al.
International Journal of Molecular Sciences|May 22, 2019
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell MalignanciesHyeon Joo Yoo, Yibin Liu, Lei Wang, et al.
Cytotherapy|March 27, 2019
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cellsLei Wang, Wenjie Gong, Sanmei Wang, et al.
Pageof 3